http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-017613-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca8dbb5ac956cd254914cbba9f27b502 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_331d8cd240e1da8fc1fea7c78a5bfe7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b381e3171848fcc3a416dc786c04e44 |
| publicationDate | 2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-017613-B1 |
| titleOfInvention | UNIVERSAL VACCINE FROM TUMOR CELLS FOR ANTI-CANCER THERAPY AND PREVENTION USE |
| abstract | The invention relates to compositions for stimulating the immune response in patients with various forms of cancer, including patients with adenocarcinoma (adenocarcinoma, for example, colon, breast, lung, prostate, pancreas, kidney, endometrium, cervix, ovary, thyroid or other glandular tissue, as well as squamous cancer, melanoma, cancer of the central nervous system and lymphoma) containing a combination of allogeneic tumor cells and / or tumor stem cells that are selected on the basis of secretion at least one immunosuppressive agent, such as TGF-β, and that are genetically modified to reduce or inhibit the expression of the specified at least one immunosuppressive agent, such as TGF-β, and which together express the spectrum of tumor-associated antigens representative of carcinoma colon, breast, lung, prostate, pancreas, kidney, endometrium, cervix, ovary, thyroid or other glandular tissue, as well as SLE Amozy cancer, melanoma, cancer of the central nervous system and lymphoma. The invention also relates to a composition comprising said combination of allogeneic tumor cells and / or tumor stem cells and an allogeneic cell expressing a cytokine or antibody that inhibits immunosuppressive molecules. |
| priorityDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 315.